Analyst Ratings for BioCryst Pharma (BCRX)
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $9.00 (Barclays)
- Average: $20.09
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.09 (+157.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
Avg. $ Target:
$20.09 (+157.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | RBC Capital | Brian Abraham | Downgrade | Sector Perform (Outperform) |
11.00 (N/A) |
8.81 (7.79) |
-11.58% | Details |
| 9/8/2026 | TD Cowen | Stacy Ku | New Coverage | Buy (N/A) |
30.00 (N/A) |
9.96 (7.79) |
-21.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
